Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 16:22:100430.
doi: 10.1016/j.lanwpc.2022.100430. eCollection 2022 May.

National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: Modelled estimates for 2010-17

Xiaozhen Lai  1   2 , Brian Wahl  3   4   5 , Wenzhou Yu  6 , Tingting Xu  7 , Haijun Zhang  1   2 , Cristina Garcia  4   5 , Ying Qin  8 , Yan Guo  2 , Zundong Yin  6 , Maria Deloria Knoll  4   5 , Hai Fang  1   9   10
Affiliations

National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: Modelled estimates for 2010-17

Xiaozhen Lai et al. Lancet Reg Health West Pac. .

Abstract

Background: Vaccination against Streptococcus pneumoniae (pneumococcus) and Haemophilus influenzae type b (Hib) is not included in China's national immunization programme. To inform China's immunization polices, we estimated annual national, regional, and provincial childhood mortality and morbidity attributable to pneumococcus and Hib in 2010-17.

Methods: We estimated proportions of pneumonia and meningitis deaths and cases attributable to pneumococcus and Hib using evidence from vaccine clinical trials and surveillance studies of bacterial meningitis and pathogen-specific case fatality ratios (CFR). Then we applied the proportions to model provincial-level pneumonia cases and deaths, meningitis deaths and meningitis CFR in children aged 1-59 months, accounting for vaccine coverage. Non-pneumonia, non-meningitis (NPNM) invasive disease cases were derived by applying NPNM meningitis ratios to meningitis estimates.

Findings: In 2010-17, annual pneumococcal deaths fell by 49% from 15 600 (uncertainty range: 10 800-17 300) to 8 000 (5 500-8 900), and Hib deaths fell by 56% from 6 500 (4 500-8 800) to 2 900 (2 000-3 900). Severe pneumococcal and Hib cases decreased by 16% to 218 200 (161 500-252 200) in 2017 and 29% to 49 900 (29 000-99 100). Estimated 2017 national three-dose coverage in private market was 1·3% for PCV and 33·4% for Hib vaccine among children aged 1-59 months. Provinces in the west region had the highest disease burden.

Interpretation: Childhood mortality and morbidity attributable to pneumococcal and Hib has decreased in China, but still substantially varied by region and province. Higher vaccine coverage could further reduce disease burden.

Funding: Bill & Melinda Gates Foundation.

Keywords: China; Haemophilus influenzae type b; Immunization; Streptococcus pneumoniae.

PubMed Disclaimer

Conflict of interest statement

HF reports grants from the Bill & Melinda Gates Foundation and Sanofi Pasteur. BW reports grants from the Bill & Melinda Gates Foundation. MDK reports grants from the Bill & Melinda Gates Foundation, Pfizer and Gavi Alliance, and personal fees from Merck. CG reports grants from the Bill & Melinda Gates Foundation and Pfizer, and personal fees from Merck. All other authors declare no competing interests.

Figures

Figure 1
Figure 1
Pathogen-specific pneumonia, meningitis, and NPNM morbidity and mortality conceptual models. NPNM=non-pneumonia, non-meningitis. CFR=case-fatality ratio.
Figure 2
Figure 2
Estimated Streptococcus pneumoniae (A) and Haemophilus influenzae type b (B) deaths and mortality in 2017. Size of bubble indicates absolute number of pathogen-specific deaths.
Figure 3
Figure 3
Mortality rates for Streptococcus pneumoniae and Haemophilus influenzae type b for 2010–2017, by region.
See this image and copyright information in PMC

References

    1. Wahl B., O'Brien K.L., Greenbaum A., et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. 2018;6(7):e744–ee57. - PMC - PubMed
    1. Wang Y., Li X., Zhou M., et al. Under-5 mortality in 2851 Chinese counties, 1996–2012: a subnational assessment of achieving MDG 4 goals in China. Lancet. 2016;387(10015):273–283. - PMC - PubMed
    1. Murphy T.V., White K.E., Pastor P., et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA. 1993;269(2):246–248. - PubMed
    1. Adegbola R.A., Secka O., Lahai G., et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet. 2005;366(9480):144–150. - PubMed
    1. Hammitt L.L., Crane R.J., Karani A., et al. Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study. Lancet Glob Health. 2016;4(3):e185–ee94. - PMC - PubMed

LinkOut - more resources